Information Provided By:
Fly News Breaks for March 3, 2017
HMSY
Mar 3, 2017 | 09:39 EDT
Raymond James analyst Nicholas Jansen said HMS Holdings' 10-K delay does not have any bearing on 2017 growth objectives and entirely relates to shrinking Medicare short stay exposure from their old Medicare RAC contract. The analyst expects a potential restatement to be immaterial and views the issue as more of a "nuisance." Jansen rates HMS Holdings an Outperform with a $23 price target.
News For HMSY From the Last 2 Days
There are no results for your query HMSY